Report cover image

United States of America (USA) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026

Publisher MarketLine
Published Feb 10, 2023
Length 50 Pages
SKU # MTLN17890360

Description

United States of America (USA) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026

Summary

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The US pharmaceuticals market had total revenues of $397.0 billion in 2021, representing a compound annual growth rate (CAGR) of 4.3% between 2016 and 2021.
  • The US government continued to invest heavily in pharmaceutical companies in 2021 to accelerate the development, manufacture, and procurement of COVID-19 vaccines and therapeutics. This has resulted in stable growth of the pharmaceuticals market.
  • New policies by the US government to reduce the pricing of medications and build an affordable healthcare system could contribute to a slowdown in market growth. As healthcare becomes more affordable and accessible, the ability of pharmaceutical companies to freely set prices will become limited.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the United States pharmaceuticals market by value in 2021?
  • What will be the size of the United States pharmaceuticals market in 2026?
  • What factors are affecting the strength of competition in the United States pharmaceuticals market?
  • How has the market performed over the last five years?
  • What are the main segments that make up the United State's pharmaceuticals market?

Table of Contents

50 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What is the rationale behind recent M&A activity
7.5. How does government regulation impact leading players?
7.6. What impact is the COVID-19 pandemic having on the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. Merck & Co., Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States pharmaceuticals market value: $ billion, 2016–21
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: United States pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: United States pharmaceuticals market share: % share, by value, 2021
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: AstraZeneca PLC: Key Employees Continued
Table 17: Merck & Co., Inc.: key facts
Table 18: Merck & Co., Inc.: Annual Financial Ratios
Table 19: Merck & Co., Inc.: Key Employees
Table 20: Merck & Co., Inc.: Key Employees Continued
Table 21: United States size of population (million), 2017–21
Table 22: United States gdp (constant 2005 prices, $ billion), 2017–21
Table 23: United States gdp (current prices, $ billion), 2017–21
Table 24: United States inflation, 2017–21
Table 25: United States consumer price index (absolute), 2017–21
Table 26: United States exchange rate, 2017–21
List of Figures
Figure 1: United States pharmaceuticals market value: $ billion, 2016–21
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2021
Figure 10: United States pharmaceuticals market share: % share, by value, 2021

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us